The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
7-Phenyl-imidazoquinolin-4(5H)-one derivatives as selective and orally available mPGES-1 inhibitors.EBI
Dainippon Sumitomo Pharma
5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor.EBI
Amira Pharmaceuticals
Treatment of allergy: Overview of synthetic anti-allergy small molecules in medicinal chemistry.EBI
Zhejiang Sci-Tech University
Novel potent benzimidazole-based microsomal prostaglandin EEBI
Gazi University
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1EBI
Orexo
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin EEBI
Goethe-University Frankfurt
Identification of multi-target inhibitors of leukotriene and prostaglandin EEBI
Gazi University
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofBDB
Novartis
Compounds and usesBDB
Astrazeneca
Compounds and uses BDB
Astrazeneca